Learn More
Medchemexpress LLC Simotinib | 944258-89-3 | 99.4% | 500.95 | C25H26ClFN4O4 | 5 MG

Supplier: Medchemexpress LLC HY1018205MG
Simotinib is a selective, orally bioavailable epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor for research use. It inhibits EGFR with an in vitro IC50 of 19.9 nM and demonstrates antineoplastic activity in preclinical studies. The compound is provided as a high-purity solid and as a DMSO solution for biochemical and cellular assays.
- Selective EGFR inhibition (IC50 19.9 nM).
- Orally bioavailable properties observed in preclinical models.
- High reported purity (99.4%).
- Available as solid and as 10 mM solution in DMSO for convenience.
- Suitable for biochemical and cellular studies targeting EGFR.
- Supplied in multiple pack sizes to support small-scale research needs.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.